FDA: Fluoroquinolones Boost Risk of Aortic Ruptures, Tears

The FDA has issued a drug safety announcement advising that fluoroquinolone antibiotics can increase the risk for aortic ruptures or tears. This class of antibiotics should be used in at-risk patients only if no other treatment options are available, warns the agency.
Source: AAFP News - Category: Primary Care Source Type: news